Total Payments
$20,944
2024 Payments
$2,215
Companies
45
Transactions
262
Medicare Patients
2,844
Medicare Billing
$456,954
Payment Breakdown by Category
Food & Beverage$9,243 (44.1%)
Consulting$6,020 (28.7%)
Travel$4,900 (23.4%)
Other$641.92 (3.1%)
Education$138.63 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,243 | 224 | 44.1% |
| Consulting Fee | $6,020 | 2 | 28.7% |
| Travel and Lodging | $4,900 | 28 | 23.4% |
| Entertainment | $641.92 | 2 | 3.1% |
| Education | $138.63 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Flowonix Medical Incorporated | $6,576 | 4 | $0 (2020) |
| Abbott Laboratories | $1,808 | 35 | $0 (2024) |
| SI-BONE, Inc. | $1,573 | 15 | $0 (2019) |
| MML US, Inc. | $1,377 | 13 | $0 (2021) |
| Medtronic, Inc. | $1,303 | 27 | $0 (2024) |
| Curonix LLC | $1,185 | 13 | $0 (2024) |
| Medtronic USA, Inc. | $1,136 | 12 | $0 (2020) |
| Southern Spine, LLC | $816.59 | 1 | $0 (2021) |
| Foundation Fusion Solutions, LLC | $661.78 | 5 | $0 (2022) |
| Nevro Corp. | $623.09 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,215 | 34 | Curonix LLC ($1,157) |
| 2023 | $596.01 | 18 | Medtronic, Inc. ($178.69) |
| 2022 | $1,342 | 30 | Foundation Fusion Solutions, LLC ($388.04) |
| 2021 | $4,440 | 62 | MML US, Inc. ($1,377) |
| 2020 | $7,887 | 40 | Flowonix Medical Incorporated ($5,930) |
| 2019 | $2,005 | 32 | Abbott Laboratories ($1,073) |
| 2018 | $1,994 | 26 | SI-BONE, Inc. ($1,368) |
| 2017 | $464.76 | 20 | Daiichi Sankyo Inc. ($150.19) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Opioid Analgesic | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $60.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.44 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/16/2024 | Bioventus LLC | SUPARTZ FX SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: DEVICES | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $118.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| Category: Opioid Analgesic | ||||||
| 08/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/08/2024 | SPINEFRONTIER, INC. | SIJFuse (Device), NanoFUSE | Food and Beverage | Cash or cash equivalent | $106.62 | General |
| Category: Orthopedic | ||||||
| 05/23/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 05/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/25/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $102.15 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/18/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $54.16 | General |
| Category: Bone Health | ||||||
| 04/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $103.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $102.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/09/2024 | SPINEFRONTIER, INC. | SIJFuse (Device), NanoFUSE | Food and Beverage | Cash or cash equivalent | $79.50 | General |
| Category: Orthopedic | ||||||
| 04/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: Diabetes Care | ||||||
| 03/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $142.42 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/09/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Opioid Analgesic | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $55.44 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 635 | 2,375 | $232,528 | $111,901 |
| 2022 | 21 | 611 | 1,832 | $179,237 | $95,241 |
| 2021 | 28 | 702 | 2,210 | $215,065 | $113,789 |
| 2020 | 34 | 896 | 2,590 | $266,432 | $136,024 |
Total Patients
2,844
Total Services
9,007
Medicare Billing
$456,954
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 184 | $28,105 | $16,671 | 59.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 25 | 44 | $24,397 | $13,369 | 54.8% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 25 | 112 | $16,146 | $8,862 | 54.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 25 | 48 | $16,705 | $7,758 | 46.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 29 | 48 | $19,150 | $7,009 | 36.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 18 | 35 | $14,642 | $6,870 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 49 | $11,090 | $6,321 | 57.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 27 | 114 | $13,077 | $5,310 | 40.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 30 | 36 | $11,776 | $5,024 | 42.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 11 | 16 | $9,660 | $4,861 | 50.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 68 | $9,344 | $4,620 | 49.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 29 | 48 | $13,625 | $4,378 | 32.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 19 | 23 | $6,623 | $4,089 | 61.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 18 | 35 | $9,950 | $3,640 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 56 | $7,123 | $3,565 | 50.0% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 16 | $5,310 | $2,918 | 54.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $6,660 | $2,685 | 40.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 56 | 111 | $2,225 | $1,361 | 61.2% |
| 20526 | Injection of carpal tunnel | Office | 2023 | 15 | 19 | $3,742 | $1,171 | 31.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 109 | $1,128 | $843.36 | 74.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 44 | 535 | $1,166 | $445.22 | 38.2% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 23 | 310 | $587.30 | $96.31 | 16.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 23 | 340 | $295.90 | $33.19 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 152 | $23,993 | $13,451 | 56.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 23 | 35 | $20,757 | $11,064 | 53.3% |
About Dr. Roland Chalifoux, DO
Dr. Roland Chalifoux, DO is a Interventional Pain Medicine healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710912498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roland Chalifoux, DO has received a total of $20,944 in payments from pharmaceutical and medical device companies, with $2,215 received in 2024. These payments were reported across 262 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,243).
As a Medicare-enrolled provider, Chalifoux has provided services to 2,844 Medicare beneficiaries, totaling 9,007 services with total Medicare billing of $456,954. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Neurological Surgery, Interventional Pain Medicine
- Location Clinton Township, MI
- Active Since 07/11/2006
- Last Updated 08/19/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710912498
Products in Payments
- Prometra II (Device) $6,576
- iFuse Implant (Device) $1,573
- SYNCHROMED (Device) $1,439
- ReActiv8 (Device) $1,377
- Proclaim Family of SCS IPGs (Device) $1,202
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $1,185
- Omnia (Device) $587.97
- INTELLIS ADAPTIVESTIM (Device) $553.20
- StimQ Receiver Stimulator Kit Channel A US w Receiver (Device) $322.55
- XTAMPZA (Drug) $311.11
- Qutenza (Drug) $255.84
- Proclaim IPG (Device) $211.63
- SIJFuse (Device) $186.12
- Cardiovascular- Research only (Device) $181.45
- RESTORE (Device) $139.71
- Belbuca (Drug) $138.89
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $136.50
- Truvada (Drug) $118.99
- QULIPTA (Drug) $118.25
- Orbactiv (Drug) $112.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.